Abstract:Background/Objectives: Osteoarthritis (OA) is a prevalent and debilitating joint disorder characterized by progressive cartilage degradation and inflammation, for which traditional treatments offer only symptomatic relief without halting disease progression. Exosomes, cell-free vesicles derived from mesenchymal stem cells, have emerged as a promising alternative therapy owing to their regenerative and anti-inflammatory properties. Methods: This review synthesizes findings from recent studies (2017–2023) on the therapeutic potential of exosomes in OA treatment, highlighting their ability to modulate the joint microenvironment, reduce inflammation, and promote cartilage repair by delivering bioactive molecules such as cytokines, growth factors, and regulatory ribonucleic acids. Results: We explore the integration of exosomes with biomaterials, such as hydrogels and scaffolds, to enhance their delivery and therapeutic efficacy, and we address the critical challenges associated with their clinical application, including standardization of isolation and characterization methods, scalability of production, mechanistic understanding, and long-term safety. Despite these challenges, exosome-based therapies offer several advantages over traditional and cell-based treatments, including lower immunogenicity, ease of handling, and targeted delivery of therapeutic agents to damaged tissues. Conclusions: We provide an analytical perspective on the current state of exosome research in OA, emphasizing the need for standardized production methods, deeper mechanistic insights, and rigorous long-term safety assessments. Future directions should focus on optimizing delivery systems, exploring personalized medicine approaches, and conducting comparative effectiveness studies to fully realize the potential of exosome therapies for OA treatment. Addressing these gaps will be crucial for translating exosome therapies from bench to bedside and achieving a transformative impact on OA management.

Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis

Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis

Exosomes derived from MSC as drug system in osteoarthritis therapy

Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis

Harnessing exosomes as cutting-edge drug delivery systems for revolutionary osteoarthritis therapy

Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis

Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis

Exosomes in the Pathogenesis, Progression, and Treatment of Osteoarthritis

Harnessing exosomes for advanced osteoarthritis therapy

The role of exosomes and their enhancement strategies in the treatment of osteoarthritis

The role and therapeutic potential of MSC-derived exosomes in osteoarthritis

The potential therapeutic role of extracellular vesicles in osteoarthritis

Advancing Osteoarthritis Treatment: The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes and Biomaterial Integration

Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?

Roles of Exosomes from Mesenchymal Stem Cells in Treating Osteoarthritis

The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy

Immunomodulation of MSCs and MSC-Derived Extracellular Vesicles in Osteoarthritis

Biomaterials-assisted exosomes therapy in osteoarthritis

Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis

Exosomes Rewire the Cartilage Microenvironment in Osteoarthritis: from Intercellular Communication to Therapeutic Strategies

Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management